Institution Directory

Clinical trials at Stanford Medicine

Sites in Stanford & Palo Alto, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1370

Shown on this page

Current sort

Live official records

Conditions: Diverticulitis
Interventions: Partial Colectomy, Medical Management; Procedure · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 29
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 24 more

Conditions: Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Interventions: Arsenic Trioxide, Cytarabine, Dexamethasone, Idarubicin, Laboratory Biomarker Analysis, Mitoxantrone Hydrochloride, Quality-of-Life Assessment, Questionnaire Administration, Tretinoin; Drug · Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: 12 Months to 21 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2029
U.S. locations: 152
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 121 more

Conditions: High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma
Interventions: Dinutuximab, Eflornithine Hydrochloride, Irinotecan Hydrochloride, Sargramostim, Temozolomide; Biological · Drug
Lead sponsor: Children's Oncology Group; Network
Eligibility: 1 Year and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 124
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Downey, California + 100 more

Conditions: Postoperative Atrial Fibrillation
Interventions: Amiodarone Injection, Intraoperative Rapid Atrial Pacing; Drug · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2050
U.S. locations: 1
States / cities: Stanford, California

Conditions: Intestinal Failure
Interventions: AI-driven total parenteral nutrition (TPN); Device
Lead sponsor: Takeoff41, Inc.; Industry
Eligibility: Up to 6 Months
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Severe Aplastic Anemia
Interventions: Haploidentical donor bone marrow transplant, Unrelated donor bone marrow transplant; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 3 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 25
States / cities: Birmingham, Alabama • Duarte, California • Los Angeles, California + 20 more

Conditions: Atrial Fibrillation, Arrhythmias, Cardiac
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 22 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Heart Failure, Congestive
Interventions: Non-invasive central venous pressure; Device
Lead sponsor: Nihon Kohden; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Bronchiolitis Acute Viral
Interventions: Educational Outreach, Audit & Feedback (unit level), Audit & Feedback (real time, individual-level), Clinical Pathway Integrated into Electronic Health Record; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Months and older
Enrollment: 9,265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 50
States / cities: Birmingham, Alabama • Davis, California • Encinitas, California + 42 more

Conditions: Heart Failure
Interventions: Acute exercise, Cardiac rehabilitation; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Stanford, California

Conditions: Acute Pancreatitis
Interventions: Dexcom Continuous Glucose Monitor (CGM); Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 13
States / cities: Los Angeles, California • Stanford, California • Gainesville, Florida + 8 more

Conditions: Income, Infant, Newborn, Mothers, Poverty, United States, Healthcare Disparities, Child Care, Child Health, Community Health Workers, Hispanic or Latino, Medicaid, Child Development, Social Services Utilization, Health Services Utilization
Interventions: Community Health Worker, Community Health Worker + Guaranteed Basic Income; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 0 Days and older
Enrollment: 2,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

About this Stanford Medicine institution page

What this page lists: ClinicalTrials.gov records that list Stanford Medicine in Stanford & Palo Alto, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Stanford Medicine

Filter and sort this campus

Live official records

Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment

AI-driven Total Parenteral Nutrition Platform

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

The Dynamics of Human Atrial Fibrillation

Comparison of Noninvasive vs. Invasive Hemodynamic Measurements

Eliminating Monitor Overuse Trial (EMO Trial)

Identifying Markers of Exercise Training in Heart Failure

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children

About this Stanford Medicine institution page